Leading the Way in Life Science Technologies

GEN Exclusives

More »

Feature Articles

More »

For full access to this article login to GEN Select now.

October 15, 2007 (Vol. 27, No. 18)

BioMarket Trends: Process Improvements Bolster Peptide Drug Market

Stability, Cost, Delivery, and Manufacturing Challenges Are Being Worked Out

  • An analysis of launched peptide drugs and compounds in late-stage development indicated that the peptide market would grow in 2006 at a rate of approximately 5%. Beginning in late 2007, Phase III and some fast-track Phase II candidates will start moving through the registration and approval process. As these ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.